Copyright
©The Author(s) 2023.
World J Diabetes. Aug 15, 2023; 14(8): 1271-1279
Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1271
Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1271
Table 5 Levels of vascular endothelial growth factor before and after treatment
Group | Number of cases | VEGF (ng/mL) | |||
Prior treatment | One month of treatment | Three months of treatment | Treatment for 6 mo | ||
Control group | 65 | 423.73 ± 76.35 | 336.73 ± 65.281 | 170.30 ± 41.321,2 | 106.32 ± 10.711,2,3 |
Observation group | 65 | 424.32 ± 77.31 | 301.62 ± 63.781 | 110.32 ± 36.721,2 | 66.79 ± 10.211,2,3 |
t value | -0.151 | 3.512 | 8.707 | 21.818 | |
P value | 0.880 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Zhan HQ, Zhou JL, Zhang J, Wu D, Gu CY. Conbercept combined with laser photocoagulation in the treatment of diabetic macular edema and its influence on intraocular cytokines. World J Diabetes 2023; 14(8): 1271-1279
- URL: https://www.wjgnet.com/1948-9358/full/v14/i8/1271.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i8.1271